🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1999-11
Trial ID
NCT00005799
Treatments Being Tested
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of Bendamu...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-04-23
Trial ID
NCT00916058
Treatments Being Tested
Purpose: To determine the safety, feasibility and effectiveness (clinical a...
Status
Completed
Location
Traumatology department. Complejo Hospitalario de Salamanca
Start Date
2012-05
Trial ID
NCT02123368
Purpose: To determine the safety, feasibility and effectiveness (clinical a...
Status
Unknown
Location
Hospital Universitario de Salamanca
Start Date
2014-06
Trial ID
NCT02365142
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Terminated
Location
Mayo Clinic Scottsdale
Start Date
2004-01-22
Trial ID
NCT00052884
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
A3D is a phase I/II clinical trial. The primary objective is to evaluate th...
Status
Recruiting
Location
University Hospital of Toulouse
Start Date
2026-05-07
Trial ID
NCT07367815
SIR-POSA is a phase II trial of peripheral blood stem cell (PBSC) transplan...
Status
Completed
Location
Ospedale San Raffaele
Start Date
2018-06-18
Trial ID
NCT03434704